Gradient Investments LLC Immuno Gen, Inc. Transaction History

Gradient Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	BUY	$3.75 - $20.05 $375 - $2,005	100 New	100 $1,000
Q2 2020 Jul 10, 2020	SELL	$3.32 - $5.34 $102 - $165	-31 Closed	0 $0
Q1 2020 Apr 07, 2020	BUY	$2.12 - $6.8 $65 - $210	31 New	31 $0
Q4 2019 Jan 15, 2020	SELL	$2.25 - $5.8 $6,896 - $17,777	-3,065 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$2.22 - $3.39 $6,804 - $10,390	3,065 New	3,065 $7,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.